October 27, 2025 16:05 ET | Source: CompoSecure, Inc. SOMERSET, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE:…
MACAO, Oct. 27, 2025 /PRNewswire/ -- CreatorWeek Macao 2025, co-organized by Macao Government Tourism Office (MGTO) and Branded, with Adbeyond Group…
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
The only cosmetics company chosen by the Ministry of Trade, Industry and Resources for the "AI Factory" project Enables agile,…
Hyundai Motor Group and Toray Group to develop advanced materials for future mobility, including high-performance vehicles and special-purpose mobilityHyundai Motor…
In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- In the heart of a refugee camp in Syria, one teacher stands tall…
By integrating compute, connectivity, applications and orchestration, RE:AI sets new standards for AI infrastructure excellence and enterprise-scale GPU-as-a-Service delivery. SAN…
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses…